12:00 AM
 | 
Feb 06, 2012
 |  BC Week In Review  |  Company News  |  Other News

Transparency Life Sciences LLC autoimmune, cardiovascular news

Transparency launched a prototype of its web platform through which patients, physicians, researchers and other stakeholders can provide input on clinical trial designs. The company believes that collaborative intelligence - what it calls "crowdsourcing" - during trial design will lead to trials that deliver results faster and at a much lower cost than conventional clinical...

Read the full 254 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >